Heron Therapeutics (HRTX) Receives CRL for HTX-011 for Management of Postoperative Pain
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/19/2026
- Nasdaq climbs as chip and AI-linked stocks bounce back
- U.S. economy is "booming," JPMorgan’s Dimon says
- Musk pledges one share of SpaceX to every U.S. child
- Brent crude edges lower, even after Houthi attacks on Saudi infrastructure
- Prepare to buy the dip as U.S. stock selloff nears its end: Morgan Stanley
| HERON THERAPEUTICS (NASDAQ: HRTX) | Delayed: 0.36 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.36 | 52 Week High | $31.32 | |||
| Open | $0.36 | 52 Week Low | $13.95 | |||
| Day High | $0.38 | P/E | N/A | |||
| Day Low | $0.35 | EPS | $-3.29 | |||
| Volume | 1,580,341 | |||||
